Skip to main content

Leiomyoma clinical trials at UCSF
1 in progress, 0 open to new patients

  • Pilot of Letrozole for Uterine Myomas

    Sorry, in progress, not accepting new patients

    PLUM evaluates the drug letrozole as a treatment for uterine fibroids. This study is a randomized, blinded, placebo-controlled trial of oral letrozole among premenopausal women with symptomatic uterine fibroids. Participants will be randomly assigned in a 1:1 ratio to either oral letrozole 2.5mg/day for 6 months (Group A) or intermittent dosing with letrozole 2.5mg/day and an identical placebo capsule (Group B).

    San Francisco, California